What is the next best step in management for a 75-year-old man with hypertension, type 2 diabetes mellitus, and hyperlipidemia who presented with a transient ischemic attack causing speech disturbance and right arm weakness lasting 90 minutes, with a normal head CT?

Management of Transient Ischemic Attack

This patient should receive dual antiplatelet therapy with aspirin (160-325 mg loading dose, then 81 mg daily) plus clopidogrel (300-600 mg loading dose, then 75 mg daily) for 21-90 days, followed by single antiplatelet therapy. 1

Rationale for Dual Antiplatelet Therapy

This 75-year-old man presents with a high-risk TIA (symptoms lasting 90 minutes with multiple vascular risk factors including diabetes, hypertension, and hyperlipidemia). The most recent World Stroke Organization guidelines (2023) provide the strongest evidence for this approach 1:

• For minor ischemic stroke (NIHSS ≤3) or high-risk TIA (ABCD2 ≥4), dual antiplatelet therapy (DAPT) with aspirin 81 mg daily and clopidogrel 75 mg daily should be initiated as early as possible, ideally within 12-24 hours of symptom onset 1

• Loading doses are critical: aspirin 160-325 mg and clopidogrel 300-600 mg should be given initially 1

• Duration: DAPT should continue for 21 days, then transition to single antiplatelet therapy for long-term secondary prevention 1

Why Not Aspirin or Clopidogrel Alone?

Single antiplatelet therapy is insufficient in the acute high-risk period:

• The American College of Chest Physicians guidelines recommend early aspirin therapy at 160-325 mg within 48 hours for acute ischemic stroke/TIA 1

• However, for long-term secondary prevention only (not acute management), they recommend single agents: aspirin 75-100 mg daily, clopidogrel 75 mg daily, or aspirin/extended-release dipyridamole 1

• The 2023 guidelines explicitly state that DAPT is superior to single antiplatelet therapy in the acute high-risk period for minor stroke/high-risk TIA 1

Blood Pressure Management

His blood pressure of 165/100 mmHg requires attention but should NOT be aggressively lowered acutely:

• In acute ischemic stroke/TIA, rapid BP reduction can worsen cerebral perfusion 1

• Target SBP <140 mmHg should be pursued after the acute period (typically after 24-48 hours) for long-term secondary prevention 1

• For patients with intracranial atherosclerotic disease (if present), SBP target <140 mmHg is specifically recommended 1

Additional Critical Management Steps

Immediate workup needed:

• Vascular imaging (carotid duplex, CTA, or MRA) to assess for carotid stenosis or intracranial atherosclerotic disease 1, 2
• Cardiac evaluation including ECG and echocardiogram to rule out atrial fibrillation or cardioembolic source 1
• If atrial fibrillation is found, anticoagulation (not antiplatelet therapy) becomes the treatment of choice 1

Risk factor modification:

• High-intensity statin therapy should be initiated regardless of baseline LDL, with target LDL <70 mg/dL 1
• Diabetes control with target fasting glucose <126 mg/dL 1
• Lifestyle modifications including smoking cessation, exercise, and dietary changes 1

Common Pitfalls to Avoid

1. Do not delay antiplatelet therapy waiting for additional testing—intracranial hemorrhage has been ruled out by CT 1

2. Do not use anticoagulation (warfarin or DOACs) for non-cardioembolic TIA, as it increases bleeding risk without additional benefit 1

3. Do not continue DAPT beyond 90 days due to increased bleeding risk without additional benefit 1

4. Do not aggressively lower BP in the acute setting (first 24-48 hours) as this may worsen cerebral ischemia 1

5. Do not forget to assess for carotid stenosis—if ≥50% symptomatic stenosis is present, carotid endarterectomy may be indicated within 2 weeks 1